Mucus Relief PE

Product NDC
21130-542
11-digit product format
211300542
Labeler code
21130
Product ID
21130-542_3c3a3447-66cc-4d8f-a4a4-73654782ae12
Type
HUMAN OTC DRUG
Nonproprietary name
Guaifenesin and Phenylephrine HCl
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Better Living Brands, LLC
Application
part341
Marketing category
OTC MONOGRAPH FINAL
Marketing start
2006-04-15
Marketing end
0000-00-00
Substance
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Active strength
400 mg/1; mg/1
NDC exclude flag
No
Listing certified through
2020-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded productproduct21130-542DDiscontinued by firm2026-10-12
excluded packagepackage21130-54221130-542-01DDiscontinued by firm2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source dateDatasetScopePackage NDCSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05excluded productproductd630ba8d3edf…732f749b63fb…
2025-12-14 17:58 UTC · source 2025-12-05excluded packagepackage21130-542-01d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26excluded productproductf5e01cc5f278…a2eaf40c39c3…
2025-08-27 00:01 UTC · source 2025-08-26excluded packagepackage21130-542-01f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-31excluded productproduct2ef7874e63bc…57b86245f4fa…
2025-04-01 02:39 UTC · source 2025-03-31excluded packagepackage21130-542-012ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28excluded productproducta1b67e2a42f9…c4cf2c586c0d…
2025-03-28 20:22 UTC · source 2025-03-28excluded packagepackage21130-542-01a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21excluded productproductcfe11265f3b6…090c488252e2…
2025-03-22 03:12 UTC · source 2025-03-21excluded packagepackage21130-542-01cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10excluded productproductcdf11ea48f46…ba0047e9e063…
2025-03-10 12:48 UTC · source 2025-03-10excluded packagepackage21130-542-01cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31excluded productproduct302b2466d912…e7b80fea0513…
2025-02-02 03:52 UTC · source 2025-01-31excluded packagepackage21130-542-01302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20excluded productproducted331223b511…672a5bd82f5f…
2025-01-20 13:05 UTC · source 2025-01-20excluded packagepackage21130-542-01ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-10excluded productproduct0efc9e666f02…f202fb6c5f17…
2025-01-11 03:41 UTC · source 2025-01-10excluded packagepackage21130-542-010efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08excluded productproductad56d346431e…cc804d4bbf1e…
2024-11-09 02:27 UTC · source 2024-11-08excluded packagepackage21130-542-01ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03excluded productproduct367a005e9d99…383a685ebd0f…
2024-10-04 04:10 UTC · source 2024-10-03excluded packagepackage21130-542-01367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09excluded productproduct557ba5c1ecfa…9c80585c8c6e…
2024-07-10 04:00 UTC · source 2024-07-09excluded packagepackage21130-542-01557ba5c1ecfa…9c80585c8c6e…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
GUAIFENESINACTIVE INGREDIENT495W7451VQMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
PHENYLEPHRINE HYDROCHLORIDEACTIVE INGREDIENT04JA59TNSJMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
GUAIFENESINACTIVE MOIETY495W7451VQMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
PHENYLEPHRINEACTIVE MOIETY1WS297W6MVMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
CELLULOSE, MICROCRYSTALLINEINACTIVE INGREDIENTOP1R32D61UMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
HYPROMELLOSESINACTIVE INGREDIENT3NXW29V3WOMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
MAGNESIUM STEARATEINACTIVE INGREDIENT70097M6I30MUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
MALTODEXTRININACTIVE INGREDIENT7CVR7L4A2DMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
POLYETHYLENE GLYCOLSINACTIVE INGREDIENT3WJQ0SDW1AMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
POVIDONESINACTIVE INGREDIENTFZ989GH94EMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
SILICON DIOXIDEINACTIVE INGREDIENTETJ7Z6XBU4MUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
SODIUM STARCH GLYCOLATE TYPE A POTATOINACTIVE INGREDIENT5856J3G2A2MUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65APMUCUS RELIEF PE (GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET, FILM COATED [SAFEWAY]5